A researcher in the UAB Comprehensive Cancer Center has been selected for the inaugural Ovarian Cancer Academy Award, part of the U.S. Department of Defense funding for cancer research. Assistant Professor Charles Landen, M.D., of the Division of Gynecologic Oncology, is one of seven early career investigators chosen for the grant. The award is $1.06 million from the Office of Congressionally Directed Medical Research.Landen works to identify and characterize a subpopulation of ovarian cancer cells that have enhanced ability to survive chemotherapy and cause recurrence. Understanding this class of cells may lead to discoveries of key pathways than can be targeted with novel anti-cancer therapies.
UAB and Southern Research joint venture to unveil first productAIMTech’s ResistX treadmill will make its debut at the American College of Sports Medicine’s annual conference.posted 2 days ago 438 viewsUAB Comprehensive Cancer Center awarded $29 million NCI core grantThe UAB Cancer Center has received a $29 million National Cancer Institute renewal grant and is re-designated as “comprehensive” with an outstanding rating as a leader in advancing cancer research and care.posted 2 days ago 862 viewsFixing cystic fibrosis: In vitro studies show therapeutically robust correction of the most common CF gene mutationCystic fibrosis lung cells were restored to 50 percent of healthy function in work that provides the first evidence that novel therapeutic strategies for human patients can be identified based on yeast studies.posted 3 days ago 1966 viewsResearcher’s lifesaving raceways invention goes internationalUAB engineering professor Dean Sicking’s SAFER Barriers will be installed at the historic Le Mans Race Circuit.posted 9 days ago 1310 viewsS&P raises UAB bond ratings on very strong financial and enterprise profilesIdentifying a stable outlook and UAB’s very strong enterprise and financial profile, S&P Global Ratings has raised its rating on various series of general revenue bonds issued by The University of Alabama System Board of Trustees on behalf of UAB.posted 9 days ago 789 viewsHIV vaccine design should adapt as HIV virus mutatesResearchers from UAB, Emory and Microsoft demonstrate that HIV has evolved to be pre-adapted to the immune response, worsening clinical outcomes in newly infected patients.posted 12 days ago 2480 viewsMore than 10 risk factors identified in readmission of pediatric neurosurgery patientsBig data provides insight into patient readmission after pediatric neurosurgery.posted 11 days ago 2230 viewsRheumatoid arthritis: seeking an answer, cell by cellUAB researchers will use a $1.8 million grant to look at single cells for altered expression of the interferon gamma receptor gene.posted 16 days ago 2000 viewsA focus on homelessness as VA and UAB researchers mark National VA Research WeekVA Research support for UAB clinicians and scientists has been important for six decades.posted 17 days ago 1224 viewsRural children at risk for worse health outcomes, higher health care costsResearchers at UAB look to integrate health care within rural communities to improve care for children.posted 16 days ago 1933 views
After 30 years at UAB, VP Marchase announces plans to retireLongtime VP for Research and Economic Development Richard B. Marchase, Ph.D., plans to retire at the end of 2016. During his tenure, UAB annual research expenditures grew from $331 million to $510 million.posted 18 days ago 2341 viewsResearchers find potential breakthrough in binge-eating disorder treatmentA treatment used for depression, Parkinson’s disease and autism shows promise to alleviate obesity in binge-eating disorder patients.posted 19 days ago 3287 viewsUAB Hospital recognized for decreasing inappropriate use of antibioticsAntibiotic use in acute and long-term care facilities is a focus of UAB’s antibiotic stewardship program.posted 22 days ago 2000 viewsTen-year-old finds relief from rare eyelash growthDaniel Deligio, O.D., treats a rare disease and provides successful treatment plan for Sam Peppers.posted 23 days ago 2031 viewsParkinson’s disease pathogenesis is reduced in a rat model using a cell-signaling inhibitor drugResults show that JAK/STAT pathway inhibitors may be a new class of therapeutic treatments for patients with Parkinson’s disease. Acting by reducing inflammation, they prevent neurodegeneration in animal models and may be an important new approach to slow progression of the disease.posted 25 days ago 2406 viewsUAB driving simulator lab has national debut live on TODAYCutting-edge technology and research brings national attention to UAB.posted 29 days ago 3342 viewsStudy shows how different people respond to aspirin — an important cardioprotective drugUnderstanding how people respond to aspirin is key in terms of knowing who will benefit from it.posted a while back 1468 viewsDepartment of Ophthalmology to host 2016 Clinical and Research SymposiumThe University of Alabama at Birmingham School of Medicine and Department of Ophthalmology will host the 2016 Annual Clinical and Research Symposium on May 13-14 at the Westin Birmingham.posted a while back 755 viewsStudy to test ways to improve cognitive functioning of older adults with HIVUAB School of Nursing Professor David Vance, Ph.D., received a five-year, $2.86 million R01 grant to test ways of improving cognitive function in older adults with HIV.posted a while back 1230 viewsFirst-of-its-kind driving simulator lab at UAB powered by donation from Honda Manufacturing of Alabama and ALDOTThe facility will enable new distracted-driving research, addressing a major public health issue that is a leading cause of highway and traffic-related injuries and death.posted a while back 3241 views